| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-09 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
| mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |